Product NDC: | 0054-0235 |
Proprietary Name: | Morphine Sulfate |
Non Proprietary Name: | Morphine Sulfate |
Active Ingredient(s): | 15 mg/1 & nbsp; Morphine Sulfate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0054-0235 |
Labeler Name: | Roxane Laboratories, Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022207 |
Marketing Category: | NDA |
Start Marketing Date: | 20080317 |
Package NDC: | 0054-0235-25 |
Package Description: | 100 TABLET in 1 BOTTLE (0054-0235-25) |
NDC Code | 0054-0235-25 |
Proprietary Name | Morphine Sulfate |
Package Description | 100 TABLET in 1 BOTTLE (0054-0235-25) |
Product NDC | 0054-0235 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Morphine Sulfate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080317 |
Marketing Category Name | NDA |
Labeler Name | Roxane Laboratories, Inc |
Substance Name | MORPHINE SULFATE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |